Cardurion Pharmaceuticals (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- July 16, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $260,000,000
Company Info
- Company Description
- Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
- Market
- Cardiovascular diseases
- Location
- Burlington, MA, USA
- Coinvestors
- Ascenta Capital, Bain Capital Life Sciences, Blue Owl, Delos Capital, Digitalis Ventures, Farallon Capital Management, Fidelity Management & Research Company, GV, Invus Capital, Millennium Management, NEA Ventures